Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SAN FRANCISCO, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced...
-
BENTONVILLE, Ark., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTCPK: GLUC), manufacturer of GLUCODOWN®, the first powdered tea and drink mixes uniquely enriched with clinically proven...
-
NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on the path...
-
RIGA, Latvia, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Pax8, the leading cloud commerce marketplace, is proud to announce the grand opening of its new office in Riga, Latvia. This significant milestone...
-
CALGARY, Alberta, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Global Helium Corp. ("HECO" or the "Company") (CSE: HECO, OTC: HECOF) is pleased to announce that on September 18, 2023, the Company successfully...
-
SAN FRANCISCO, Sept. 20, 2023 (GLOBE NEWSWIRE) -- The Federal Home Loan Bank of San Francisco (FHLBank San Francisco) today announced it has doubled its commitment for its groundbreaking and...
-
HAMILTON, Ontario, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology...
-
NEWTOWN, Pa., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic...
-
CALGARY, Alberta, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Helium Evolution Incorporated (TSXV:HEVI) ("HEVI" or the "Company"), a Canadian-based helium exploration company focused on developing assets in...
-
JERUSALEM, Sept. 19, 2023 (GLOBE NEWSWIRE) -- via IBN – Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on developing, manufacturing, and commercializing...